Themis Bioscience
Closed- Business Model
- B2B
About
Themis Bioscience developed vaccines and immune-modulation therapies for infectious diseases. The company applied a platform based on original Institut Pasteur discoveries and was developing vaccine programs for diseases including SARS, Chikungunya, MERS, Lassa fever, and COVID-19. Merck announced in 2020 that a subsidiary would acquire all outstanding Themis shares, making the company a wholly owned Merck subsidiary when the transaction closed.
Summary
Themis Bioscience is a Biotech company.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/themis-bioscience"><img src="https://indexed.vc/api/badge/company/themis-bioscience" alt="Themis Bioscience on Indexed.vc" width="260" height="76" /></a>